Kokuma, which is based on medtech and pharmaceutical expertise with a mix of Al-driven research has spent two years on intensive R&D to create novel and unique active ingredients for melanin management.
Its team of scientific experts have garnered plenty of experience in leading medical and cosmetics companies and have now taken this knowledge to create cosmetics ingredients that have already demonstrated efficacy in ex-vivo and in-vivo testing.
We spoke to CEO and co-founder Alexandre Jouve who has a background in pharmaceutical development at Sanofi and Servier, as well as a track record of scaling biotech and medtech startups.
Jouve founded the company with chief scientific officer Yannick Quesnel, Ph.D who has a plethora of expertise in chemistry and biopharma/tech and a "profound understanding of physiological pathways."
The two are joined by board member and operational advisor Olivier
Fontaine who has spent over 30 years in leadership roles at L'Oréal, The Estée Lauder Companies, and Pierre Fabre.
Alexandre Jouve (AJ): Tonasulike-D is a natural compound isolated using Al, validated ex-vivo, and shown to reduce melanin production by up to 86% in in-vitro tests. It targets hyperpigmentation, offering a safer, science-backed solution.
This ingredient is ideal for creams and serums, designed to visibly lighten age spots and pigmentation, ensuring a smooth and even skin tone.
Tonasulike-P is a clinically validated active ingredient that doubles melanin production ex-vivo without sun exposure, providing a long-lasting, natural glow. As the world's first UV-free melanin booster, it is naturally derived and safe, making it ideal for skincare products and active makeup formulations.
We also have a robust pipeline of future ingredients targeting anti-ageing and other advanced skin care innovations, all of which are designed to meet the highest international standards of efficacy and safety.
Alexandre Jouve (AJ): Tonasulike-D is a natural compound isolated using Al, validated ex-vivo, and shown to reduce melanin production by up to 86% in in-vitro tests. It targets hyperpigmentation, offering a safer, science-backed solution.
This ingredient is ideal for creams and serums, designed to visibly lighten age spots and pigmentation, ensuring a smooth and even skin tone.
Tonasulike-P is a clinically validated active ingredient that doubles melanin production ex-vivo without sun exposure, providing a long-lasting, natural glow. As the world's first UV-free melanin booster, it is naturally derived and safe, making it ideal for skincare products and active makeup formulations.
We also have a robust pipeline of future ingredients targeting anti-ageing and other advanced skin care innovations, all of which are designed to meet the highest international standards of efficacy and safety.
